Trieu Vuong - Sep 26, 2022 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Stock symbol
OTLC
Transactions as of
Sep 26, 2022
Transactions value $
$1,360
Form type
4
Date filed
9/28/2022, 09:15 AM
Previous filing
Aug 29, 2022
Next filing
Nov 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $1.36K +20K +0.02% $0.07 90.4M Sep 26, 2022 Direct
holding OTLC Common Stock 16.8M Sep 26, 2022 By Autotelic, Inc.
holding OTLC Common Stock 6.87M Sep 26, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Dr. Trieu purchased 20,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity on September 26, 2022 from the open market at a price of $0.068.